Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rapacuronium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Raplon, 156137-99-4, Org 9487, Org-9487, 156137-99-4 (bromide), 65q4qdg4kc
    Molecular Formula
    C37H61BrN2O4
    Molecular Weight
    677.8  g/mol
    InChI Key
    LVQTUXZKLGXYIU-GWSNJHLMSA-M
    FDA UNII
    65Q4QDG4KC
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-acetyloxy-10,13-dimethyl-2-piperidin-1-yl-16-(1-prop-2-enylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate;bromide
    2.1.2 InChI
    InChI=1S/C37H61N2O4.BrH/c1-6-20-39(21-12-9-13-22-39)32-24-30-28-15-14-27-23-33(42-26(3)40)31(38-18-10-8-11-19-38)25-37(27,5)29(28)16-17-36(30,4)35(32)43-34(41)7-2;/h6,27-33,35H,1,7-25H2,2-5H3;1H/q+1;/p-1/t27-,28+,29-,30-,31-,32-,33-,35-,36-,37-;/m0./s1
    2.1.3 InChI Key
    LVQTUXZKLGXYIU-GWSNJHLMSA-M
    2.1.4 Canonical SMILES
    CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-]
    2.1.5 Isomeric SMILES
    CCC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-]
    2.2 Other Identifiers
    2.2.1 UNII
    65Q4QDG4KC
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Org 9487

    2. Org-9487

    3. Rapacuronium

    4. Raplon

    2.3.2 Depositor-Supplied Synonyms

    1. Raplon

    2. 156137-99-4

    3. Org 9487

    4. Org-9487

    5. 156137-99-4 (bromide)

    6. 65q4qdg4kc

    7. 1-((2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3-acetoxy-10,13-dimethyl-2-(piperidin-1-yl)-17-(propionyloxy)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-allylpiperidin-1-ium Bromide

    8. Raplon (tn)

    9. Ncgc00183839-01

    10. Unii-65q4qdg4kc

    11. Rapacuronium Bromide [usan:inn:ban]

    12. Dsstox_cid_28749

    13. Dsstox_rid_83018

    14. Dsstox_gsid_48823

    15. Schembl41132

    16. 1-(3alpha-acetoxy-2beta-(1-piperidinyl)-17beta-(propionyloxy)-5alpha-androsta-16beta-yl)-1-allylpiperidinium Bromide

    17. Chembl1200549

    18. Dtxsid7048823

    19. Rapacuronium Bromide [mi]

    20. Rapacuronium Bromide (usan/inn)

    21. Rapacuronium Bromide [inn]

    22. Rapacuronium Bromide [usan]

    23. Rapacuronium Bromide [vandf]

    24. Tox21_113304

    25. Rapacuronium Bromide [mart.]

    26. Rapacuronium Bromide [who-dd]

    27. Cs-6564

    28. 1-allyl-1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta-yl)piperidinium Bromide, 3-acetate 17-propionate

    29. Hy-16423

    30. Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide

    31. Rapacuronium Bromide [orange Book]

    32. Cas-156137-99-4

    33. D05703

    34. Q3419354

    35. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3-acetyloxy-10,13-dimethyl-2-piperidin-1-yl-16-(1-prop-2-enylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl] Propanoate;bromide

    36. 1-allyl-1-(3.alpha.,17.beta.-dihydroxy-2.beta.-piperidino-5.alpha.-androstan-16.beta.-yl)piperidinium Bromide, 3-acetate 17-propionate

    2.4 Create Date
    2005-12-16
    3 Chemical and Physical Properties
    Molecular Weight 677.8 g/mol
    Molecular Formula C37H61BrN2O4
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count9
    Exact Mass676.38147 g/mol
    Monoisotopic Mass676.38147 g/mol
    Topological Polar Surface Area55.8 Ų
    Heavy Atom Count44
    Formal Charge0
    Complexity1030
    Isotope Atom Count0
    Defined Atom Stereocenter Count10
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Neuromuscular Nondepolarizing Agents

    Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)